However, in the current study, multivariate analysis demonstrated that preT790M was the independent factor related to a poor prognosis in patients with resected EGFR-mutated NSCLC, irrespective of patient background including pathological stage, age, EGFR mutation subtype, and history of adjuvant chemotherapy. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.